Structure/Function Analysis of Phagocyte Proteins
Structure/Function Analysis of Phagocyte Proteins
批准号:
6382862
负责人:
Mary C Dinauer
金额:
$29.8万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-12-02 至 2006-06-30
关键词:
NAD(P)H dehydrogenase cell line cytochrome b enzyme activity enzyme biosynthesis enzyme complex enzyme mechanism enzyme structure flavoproteins human subject laboratory mouse leukocyte oxidative burst molecular assembly /self assembly phagocytes phagocytosis protein structure function respiratory burst oxidase site directed mutagenesis tissue /cell culture transfection
中文摘要
性状(申请人提供):吞噬细胞呼吸爆发氧化酶
产生超氧化物自由基在宿主防御中起着核心作用,
炎症反应。活性氧化酶复合物的组装需要
膜和胞质蛋白的参与,并受
小GTP一种吞噬细胞特异性b型黄细胞色素异二聚体,位于
在血浆和中性粒细胞中,特异性颗粒膜是病灶
点氧化酶组装,并含有黄素和血红素氧化还原中心
用于将电子从NADPH转移到分子氧。中的遗传缺陷
氧化酶蛋白,包括两个黄细胞色素亚基,导致慢性
肉芽肿性疾病(CGD),一种以呼吸道疾病缺失为特征的综合征,
爆裂、复发性感染和慢性肉芽肿。的结构和
各种氧化酶亚基和组装之间的功能关系
活性NADPH氧化酶复合物的活性仍不完全清楚。这
低电位黄细胞色素是由gp 91 phox,91-kDa的
由X连锁基因编码的糖蛋白,是
X-连接的CGD,和p221-phOx,一种衍生自
常染色体CGD基因座拟议的研究采取遗传学方法,
研究黄细胞色素氧化酶B的结构和功能,
其作为组装活性NADPH氧化酶复合物的焦点的作用。的
该项目有3个具体目标,利用了GP 91 phox
通过基因靶向开发的缺陷型吞噬细胞细胞系以及
我们已经开发了异源细胞系统,用于表达功能性
重组氧化酶亚基。首先,gp 91 phox和
p22 phox在黄细胞色素B生物合成和功能中的作用将用
用于表达未组装的亚基的异源细胞,所述未组装的亚基在其它情况下是
在吞噬细胞中不稳定。第二,鉴定gp 91 phox和p22中的结构域
在氧化酶活性组装和调节中起作用的phox将
追求,使用强调定点诱变的策略,
候选亲水区域,随后表达和分析功能
在完整的细胞中。第三,对黄细胞色素B重要的功能域
将研究吞噬过程中的运输和NADPH氧化酶组装
在异源和吞噬细胞系中使用类似的方法。这些
研究将进一步深入了解超氧化物生成系统,
吞噬细胞,这可能导致新的方法在调节超氧化物
在炎症反应和宿主防御中的形成。
英文摘要
DESCRIPTION (provided by applicant): The phagocyte respiratory burst oxidase
that generates the superoxide radical plays a central role in host defense and
the inflammatory response. Assembly of the active oxidase complex requires the
participation of both membrane and cytosolic proteins, and is regulated by
small GTPases. A phagocyte-specific b-type flavocytochrome heterodimer, located
in the plasma and, in neutrophils, specific granule membranes, is the focal
point for oxidase assembly, and contains both the flavin and heme redox centers
for transfer of electrons from NADPH to molecular oxygen. Genetic defects in
oxidase proteins, including the two flavocytochrome subunits, result in chronic
granulomatous disease (CGD), a syndrome characterized by an absent respiratory
burst, recurrent infections, and chronic granulomas. The structural and
functional relationships between the various oxidase subunits and the assembly
of the active NADPH oxidase complex remain incompletely understood. This
low-potential flavocytochrome is a heterodimer comprised of gp91 phox, a 91-kDa
glycoprotein encoded by an X-linked gene that is the site of mutations in
X-linked CGD, and p221-phOx, a non-glycosylated peptide derived from an
autosomal CGD locus. The proposed studies take a genetic approach to
investigating the structure and function of the oxidase flavocytochrome b and
its role as a focal point for assembly of the active NADPH oxidase complex. The
project has 3 specific objectives, which take advantage of a gp91 phox
deficient phagocyte cell line developed by gene targeting as well as
heterologous cell systems we have developed for expression of functional
recombinant oxidase subunits. First, the relative roles of gp91 phox and
p22phox in flavocytochrome b biosynthesis and function will be examined using
heterologous cells for expression of unassembled subunits, which are otherwise
unstable in phagocytes. Second, identification of domains in gp91 phox and p22
phox that function in the assembly and regulation of oxidase activity will
pursued, using a strategy that emphasizes site-directed mutagenesis of
candidate hydrophilic regions followed by expression and analysis of function
in intact cells. Third, functional domains important for flavocytochrome b
trafficking and NADPH oxidase assembly during phagocytosis will be investigated
using similar approaches in heterologous and phagocytic cell lines. These
studies will provide further insight into the superoxide-generating system of
the phagocyte, which may lead to new approaches in modulating superoxide
formation in the inflammatory response and host defense.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SELECTIVE DELETION OF NEUTROPHIL NADPH OXIDASE AND INNATE RESPONSES TO ASPERGILLUS FUMIGATUS
-
批准号:9368526
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2017
-
负责人:Mary C Dinauer
-
依托单位:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
-
批准号:7458723
-
项目类别:
-
资助金额:$44.39万
-
财政年份:2007
-
负责人:Mary C Dinauer
-
依托单位:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
-
批准号:7440956
-
项目类别:
-
资助金额:$42.19万
-
财政年份:2006
-
负责人:Mary C Dinauer
-
依托单位:
2005 Phagocytes Gordon Conference
-
批准号:7001142
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2005
-
负责人:Mary C Dinauer
-
依托单位:
Administrative
-
批准号:7414661
-
项目类别:
-
资助金额:$8.37万
-
财政年份:2005
-
负责人:Mary C Dinauer
-
依托单位:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
-
批准号:7089588
-
项目类别:
-
资助金额:$43.23万
-
财政年份:2005
-
负责人:Mary C Dinauer
-
依托单位:
Core C- Administrative Core
-
批准号:6987703
-
项目类别:
-
资助金额:$7.29万
-
财政年份:2004
-
负责人:Mary C Dinauer
-
依托单位:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
-
批准号:6879596
-
项目类别:
-
资助金额:$40.27万
-
财政年份:2004
-
负责人:Mary C Dinauer
-
依托单位:
Regulation of phagocyte function by Rac2
-
批准号:6595706
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2002
-
负责人:Mary C Dinauer
-
依托单位:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
-
批准号:6105676
-
项目类别:
-
资助金额:$12.08万
-
财政年份:1998
-
负责人:Mary C Dinauer
-
依托单位:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
-
批准号:6110406
-
项目类别:
-
资助金额:$20.42万
-
财政年份:1998
-
负责人:Mary C Dinauer
-
依托单位:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
-
批准号:6239212
-
项目类别:
-
资助金额:$13.0万
-
财政年份:1997
-
负责人:Mary C Dinauer
-
依托单位:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
-
批准号:6273016
-
项目类别:
-
资助金额:$20.23万
-
财政年份:1997
-
负责人:Mary C Dinauer
-
依托单位:
Gene Replacement Therapy in Hematopoietic Stem Cells
-
批准号:6962270
-
项目类别:
-
资助金额:$170.15万
-
财政年份:1996
-
负责人:Mary C Dinauer
-
依托单位:
Gene Replacement Therapy in Hematopoietic Stem Cells
-
批准号:7260360
-
项目类别:
-
资助金额:$170.14万
-
财政年份:1996
-
负责人:Mary C Dinauer
-
依托单位:
Gene Replacement Therapy in Hematopoietic Stem Cells
-
批准号:7458729
-
项目类别:
-
资助金额:$170.95万
-
财政年份:1996
-
负责人:Mary C Dinauer
-
依托单位:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
-
批准号:6242400
-
项目类别:
-
资助金额:$19.0万
-
财政年份:1996
-
负责人:Mary C Dinauer
-
依托单位:
Gene Replacement Therapy in Hematopoietic Stem Cells
-
批准号:7090852
-
项目类别:
-
资助金额:$170.36万
-
财政年份:1996
-
负责人:Mary C Dinauer
-
依托单位:
GENE REPLACEMENT THERAPY IN HEMATOPOIETIC STEM CELLS
-
批准号:6530677
-
项目类别:
-
资助金额:$153.05万
-
财政年份:1994
-
负责人:Mary C Dinauer
-
依托单位:
GENE REPLACEMENT THERAPY IN HEMATOPOIETIC STEM CELLS
-
批准号:2839013
-
项目类别:
-
资助金额:$122.53万
-
财政年份:1994
-
负责人:Mary C Dinauer
-
依托单位:
海外基金